Evidence map›Paper›PMID 42639279›Full record

ArticleCureus2026

A Rare Case of Pleural Deciduoid Mesothelioma With Histological, Immunohistochemical, Fluorescent In Situ Hybridization, and Ultrastructural Findings.

Hiroshi Sonobe, Rika Omote, Eito Niman, Kenji Takahashi, Kazuki Nabeshima

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroshi SonobeDepartment of Diagnostic Pathology, National Hospital Organization (NHO) Fukuyama Medical Center, Fukuyama, JPN.
Rika OmoteDepartment of Diagnostic Pathology, National Hospital Organization (NHO) Fukuyama Medical Center, Fukuyama, JPN.
Eito NimanDepartment of Thoracic Surgery, National Hospital Organization (NHO) Fukuyama Medical Center, Fukuyama, JPN.
Kenji TakahashiDepartment of Thoracic Surgery, National Hospital Organization (NHO) Fukuyama Medical Center, Fukuyama, JPN.
Kazuki NabeshimaDepartment of Diagnostic Pathology, Pathological Diagnosis Center, Fukuoka Tokushukai Hospital, Fukuoka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to the rarity of deciduoid mesotheliomas, few studies have reported detailed morphological analyses. Here, we report a case of deciduoid mesothelioma along with cytological, histological, immunohistochemical, fluorescent in situ hybridization (FISH), and electron microscopic findings. The patient was a 75-year-old man with a history of asbestos exposure. Computed tomography revealed multiple nodular shadows in the left pleura, and pleural effusion. Pleural effusion cytology revealed large epithelioid tumor cells with high nuclear atypia, suggesting epithelioid mesothelioma. A biopsy revealed that the tumor tissue consisted of sheets of highly atypical, large epithelioid cells of various sizes. Immunostaining revealed that the tumor cells were positive for mesothelial cell markers, including calretinin, Wilms tumor 1, and podoplanin, and showed loss of expression of BRCA1-associated protein 1, methylthioadenosine phosphorylase, and merlin/neurofibromatosis 2. Furthermore, cyclin-dependent kinase inhibitor 2A-FISH revealed a high frequency of homozygous deletions. Based on these findings, the tumor was diagnosed as a deciduoid mesothelioma. Reflecting the histological features, electron microscopy revealed that the tumor exhibited sheets of large epithelioid cells containing round nuclei with single or multiple distinct nucleoli, and intracytoplasmic intermediate filaments; however, microvillous structures were not evident. After the diagnosis was confirmed, the patient was treated with a combination of immune checkpoint inhibitors and chemotherapy. Long-term follow-up is required, although no disease progression was observed seven months after the initiation of therapy.

Indexed as

deciduoid mesotheliomafluorescent in situ hybridizationimmunohistochemistrypleuraultrastructure

Identifiers

PMID42639279
PMCPMC13500980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.